SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 48.75 |
| Enterprise Value ($M) | 5.12 |
| Book Value ($M) | 91.81 |
| Book Value / Share | 2.81 |
| Price / Book | 0.53 |
| NCAV ($M) | 65.46 |
| NCAV / Share | 2.00 |
| Price / NCAV | 0.74 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.93 |
| Return on Assets (ROA) | -0.49 |
| Return on Equity (ROE) | -0.57 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 4.95 |
| Current Ratio | 4.95 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 101.05 |
| Assets | 127.39 |
| Liabilities | 35.59 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | -97.74 |
| Net Income | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -82.37 |
| Cash from Investing | -37.67 |
| Cash from Financing | 88.75 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Rtw Investments, Lp | 0.00 | -100.00 | |
| 13G/A | Point72 Asset Management, L.P. | 8.20 | 43.01 | |
| 13G/A | Janus Henderson Group Plc | 1.60 | -77.65 | |
| 13G | Suvretta Capital Management, Llc | 5.10 | 0.00 | |
| 13G/A | Viking Global Investors Lp | 4.50 | 0.00 | |
| 13G/A | Qatar Investment Authority | 3.82 | 0.00 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 37,858 | 163,112 | 23.21 | |
| 15,446 | 60,818 | 25.40 | |
| 19,970 | 76,930 | 25.96 | |
| 42,541 | 210,725 | 20.19 | |
| 36,728 | 118,049 | 31.11 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| PBYI – Puma Biotechnology, Inc. | PCRX – Pacira BioSciences, Inc. |
| PCVX – Vaxcyte, Inc. | PGEN – Precigen, Inc. |
| PHAT – Phathom Pharmaceuticals, Inc. |
Financial data and stock pages provided by
Fintel.io